The biphasic effects of cyclopentenone prostaglandins, prostaglandin J 2 and 15-deoxy-Δ12,14-prostaglandin J2 on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells

Biochemical Pharmacology

Volumn 67, Issue 7, 2004, Pages 1259-1267

  Emi, Maiko ^a   Maeyama, Kazutaka ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

15 deoxy 12,14 PGJ2; 15d PGJ2; DP receptor; PCR; Peroxisome proliferator activated receptor; PG; Polymerase chain reaction; PPAR; Prostaglandin; Rat basophilic leukemia; RBL; Reactive oxygen species; ROS

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 9; DNA FRAGMENT; HISTAMINE; HORMONE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROSTAGLANDIN J2; TROGLITAZONE;

AGONIST; ANIMAL CELL; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; IMMUNOSTIMULATION; MAST CELL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 9; CASPASES; CELL DIVISION; CYCLOPENTANES; DRUG INTERACTIONS; ENZYME INHIBITORS; HISTAMINE; LEUKEMIA, BASOPHILIC, ACUTE; PROSTAGLANDIN D2; PROSTAGLANDINS; RATS; TUMOR CELLS, CULTURED;

EID: 1542345746     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.10.037     Document Type: Article

References (45)

1. Metcalfe D.D., Baram D., Mekori Y.A. Mast cells. Physiol. Rev. 77:1997;1033-1079.
2. 2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol. 129:1982;1627-1631.
3. 2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J. Immunol. 133:1984;2138-2144.
4. 2 in sleep-wake regulation: recent progress and perspectives. Neuroscientist. 8:2002;12-15.
5. 2 as a mediator of allergic asthma. Science. 287:2000;2013-2017.
6. Urade Y., Ujihara M., Horiguchi Y., Igarashi M., Nagata A., Ikai K., Hayaishi O. Mast cells contain spleen-type prostaglandin D synthetase. J. Biol. Chem. 265:1990;371-375.
7. 2 - anti-tumour and anti-viral activities and the mechanisms involved. Eicosanoids. 3:1990;189-199.
8. 2 metabolite generated during inflammatory processes. J. Biol. Chem. 277:2002;10459-10466.
9. Narumiya S., Ohno K., Fujiwara M., Fukushima M. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. J. Pharmacol. Exp. Ther. 239:1986;506-511.
10. 2 binds to and activates H-Ras. Proc. Natl. Acad. Sci. U.S.A. 100:2003;4772-4777.
11. Jiang C., Ting A.T., Seed B. PPARγ agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:1998;82-86.
12. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 391:1998;79-82.
13. 2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. J. Biol. Chem. 276:2001;38152-38158.
14. Sugiyama H., Nonaka T., Kishimoto T., Komoriya K., Tsuji K., Nakahata T. Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation. Eur. J. Immunol. 30:2000;3363-3370.
15. Sugiyama H., Nonaka T., Kishimoto T., Komoriya K., Tsuji K., Nakahata T. Peroxisome proliferator-activated receptors are expressed in mouse bone marrow-derived mast cells. FEBS Lett. 467:2000;259-262.
16. Diaz B.L., Fujishima H., Kanaoka Y., Urade Y., Arm J.P. Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow-derived mast cells by exogenous but not endogenous prostanoids. J. Immunol. 168:2002;1397-1404.
17. Mekori YA, Hartmann K, Metcalfe DD. Mast cell apoptosis and its regulation. Signal transduction. In: Radzin JR, editor. Mast cells and basophils. New York: Springer Velag; 1998. p. 85-94.
18. Hartmann K., Wagelie-Steffen A.L., von Stebut E., Metcalfe D.D. Fas (CD95, APO-1) antigen expression and function in murine mast cells. J. Immunol. 159:1997;4006-4014.
19. Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature. 352:1991;345-347.
20. Yin C., Knudson C.M., Korsmeyer S.J., Van Dyke T. Bax suppressed tumorigenesis and stimulates apoptosis in vivo. Nature. 385:1997;637-640.
21. Yamatodani A., Fukuda H., Wada H., Iwaeda T., Watanabe T. High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. J. Chromatogr. 344:1985;115-123.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods. 16:1983;55-63.
23. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
24. Makino H., Ishizaka Y., Tsujimoto A., Nakamura T., Onda M., Sugimura T., Nagao M. Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Proc. Natl. Acad. Sci. U.S.A. 89:1992;4850-4854.
25. 2, to glutathione. Biochim. Biophys. Acta. 1584:2002;37-45.
26. Wilmer W.A., Dixon C., Lu L., Hilbelink T., Rovin B.H. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARγ Biochem. Biophys. Res. Commun. 281:2001;57-62.
27. 2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J. Immunol. 168:2002;1372-1379.
28. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature. 403:2000;103-108.
29. Peden D.B., Dailey L., DeGraff W., Mitchell J.B., Lee J.G., Kaliner M.A., Hohman R.J. Hydrogen peroxide effects on rat mast cell function. Am. J. Physiol. 267:1994;L85-L93.
30. Narumiya S., Fukushima M. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J. Pharmacol. Exp. Ther. 239:1986;500-505.
31. 2 inhibits multiple steps in the NF-κB signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 97:2000;4844-4849.
32. 2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of IκB α degradation using a peroxisome proliferator-activated receptor γ-independent mechanism. J. Immunol. 168:2002;6232-6243.
33. 2: the endogenous electrophile that induces neuronal apoptosis. Proc. Natl. Acad. Sci. U.S.A. 99:2002;7367-7372.
34. Silva A., Wyllie A., Collins M.K. p53 is not required for regulation of apoptosis or radioprotection by interleukin-3. Blood. 89:1997;2717-2722.
35. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell. 78:1994;539-542.
36. 2 induce apoptosis in normal and malignant B-lineage cells. J. Immunol. 165:2000;6941-6948.
37. Ishizuka T., Chayama K., Takeda K., Hamelmann E., Terada N., Keller G.M., Johnson G.L., Gelfand E.W. Mitogen-activated protein kinase activation through Fcε receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J. Immunol. 162:1999;2087-2094.
38. Domen J., Weissman I.L. Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other. J. Exp. Med. 192:2000;1707-1718.
39. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
40. 2 generation in immature mouse mast cells. J. Biol. Chem. 270:1995;3239-3246.
41. Kondo M., Oya-Ito T., Kumagai T., Osawa T., Uchida K. Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J. Biol. Chem. 276:2001;12076-12083.
42. Xiang Z., Ahmed A.A., Moller C., Nakayama K., Hatakeyama S., Nilsson G. Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation. J. Exp. Med. 194:2001;1561-1569.
43. Asai K., Kitaura J., Kawakami Y., Yamagata N., Tsai M., Carbone D.P., Liu F.T., Galli S.J., Kawakami T. Regulation of mast cell survival by IgE. Immunity. 14:2001;791-800.
44. 2 on glutathione induction and apoptosis in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 21:2001;1846-1851.
45. Bureau F., Desmet C., Melotte D., Jaspar F., Volanti C., Vanderplasschen A., Pastoret P.-P., Piette J., Lekeux P. A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: oxidative stress-induced extracellular signal-regulated kinase activation without NF-κB inhibition. J. Immunol. 168:2002;5318-5325.